Speaker illustration

Doctor Thomas Cuisset

Hospital La Timone of Marseille, Marseille (France)

All patients with atherosclerotic disease should receive long-term intensified antithrombotic treatment beyond aspirin for secondary prevention - CON.

Event: ESC Congress 2019

Topic: Pharmacology and Pharmacotherapy

Session: Controversies in antithrombotic treatment for primary and secondary prevention

Thumbnail

Event prevention.

Event: ESC Congress 2019

Topic: Clinical

Session: 2019 ESC Guidelines on Chronic Coronary Syndromes

Thumbnail

New strategies in STEMI and cardiogenic shock.

Event: ESC Congress 2018

Topic: Primary Percutaneous Coronary Intervention (PCI)

Session: 2018 update in interventional cardiology

Thumbnail

Prolonged P2Y12 inhibition or Factor Xa inhibition in patients after an acute coronary syndrome

Event: ESC Congress 2018

Topic: Treatment

Session: Innovative strategies for secondary prevention

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb